136 related articles for article (PubMed ID: 10494769)
1. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency.
Liberti G; Bertina RM; Rosendaal FR
Thromb Haemost; 1999 Sep; 82(3):1093-6. PubMed ID: 10494769
[TBL] [Abstract][Full Text] [Related]
2. Free protein S deficiency is a risk factor for venous thrombosis.
Faioni EM; Valsecchi C; Palla A; Taioli E; Razzari C; Mannucci PM
Thromb Haemost; 1997 Nov; 78(5):1343-6. PubMed ID: 9408016
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
5. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families.
Castoldi E; Maurissen LF; Tormene D; Spiezia L; Gavasso S; Radu C; Hackeng TM; Rosing J; Simioni P
Haematologica; 2010 Apr; ():. PubMed ID: 20378562
[TBL] [Abstract][Full Text] [Related]
6. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification.
Brouwer JL; Veeger NJ; van der Schaaf W; Kluin-Nelemans HC; van der Meer J
Br J Haematol; 2005 Mar; 128(5):703-10. PubMed ID: 15725093
[TBL] [Abstract][Full Text] [Related]
7. Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status.
Franchi F; Biguzzi E; Martinelli I; Bucciarelli P; Palmucci C; D'Agostino S; Peyvandi F
Thromb Res; 2013 Aug; 132(2):e152-7. PubMed ID: 23920430
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA).
Baggio B; Budakovic A; Perissinotto E; Maggi S; Cantaro S; Enzi G; Grigoletto F;
Nephrol Dial Transplant; 2005 Jan; 20(1):114-23. PubMed ID: 15572387
[TBL] [Abstract][Full Text] [Related]
9. Venous thrombosis, oral contraceptives and high factor VIII levels.
Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.
Bombeli T; Basic A; Fehr J
Am J Hematol; 2002 Jun; 70(2):126-32. PubMed ID: 12111785
[TBL] [Abstract][Full Text] [Related]
11. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
[TBL] [Abstract][Full Text] [Related]
12. Venous thrombosis: prevalence of prothrombotic defects in north Indian population.
Bhattacharyya M; Kannan M; Chaudhry VP; Saxena R
Indian J Pathol Microbiol; 2003 Oct; 46(4):621-4. PubMed ID: 15025358
[TBL] [Abstract][Full Text] [Related]
13. Low cut-off values increase diagnostic performance of protein S assays.
Mulder R; Ten Kate MK; Kluin-Nelemans HC; Mulder AB
Thromb Haemost; 2010 Sep; 104(3):618-25. PubMed ID: 20539904
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
Pabinger I; Schneider B
Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
16. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.
de Visser MC; Poort SR; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2001 Jun; 85(6):1011-7. PubMed ID: 11434677
[TBL] [Abstract][Full Text] [Related]
17. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulability states in upper-extremity deep venous thrombosis.
Leebeek FW; Stadhouders NA; van Stein D; Gómez-García EB; Kappers-Klunne MC
Am J Hematol; 2001 May; 67(1):15-9. PubMed ID: 11279652
[TBL] [Abstract][Full Text] [Related]
19. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
Martinelli I; Taioli E; Battaglioli T; Podda GM; Passamonti SM; Pedotti P; Mannucci PM
Arch Intern Med; 2003 Dec 8-22; 163(22):2771-4. PubMed ID: 14662632
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
